About the 2nd Annual Neuroscience Innovation Forum
Building on the success on our last year's forum we are pleased to announce The 2nd Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology to take place at the Marines' Memorial Club, San Francisco on the 6th of January 2019, a day before the JP Morgan meeting.
The program will cover BioPartnering for CNS, with industry keynotes and panels on AD, PD, Neuropsychiatry and Pain Management. Moreover there are panels on innovation in NeuroTech covering banking, device, diagnostics and software.
The target audience are buy and sell side analysts from investment banks and funds and partnering executives from pharma and medtech companies. We anticipate around 200 delegates and 20+ company presentations by established public, private and emerging companies. There are numerous networking opportunities available via an online One-2-One meeting system with dedicated meeting facilities to make the event more transactional.
Topics discussed in 2018 included:
Speakers & Chairs in last year's forum included:
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business.
Presenting Companies in 2018 included:
Supporters in 2018:
Advent France Biotechnology
Alpha Omega LLC
Arthurian Life Sciences Ltd.
Bay City Capital LLC
Bioscience Managers Limited - VC fund
Biotech Alliances International, Inc.
Bradley Woods & Co.
Brookline Capital Markets
Clarus Ventures, LLC
Earlybird Venture Capital
Epidarex Capital Management LLP
Excellentia Global Partners
H.C. Wainwright & Co., LLC
HBM Partners AG
HealthCare Royalty Partners
Hercules Technology Growth Capital, Inc.
INKEF Capital BV
JDRF T1D Fund
Junewicz & Co., Inc.
L2 Capital, LLC
Life Science Angels
View Full List >>>